TrademarkDir
PRO-XTEN
DEAD

Serial Number

97059027

Owner

Amunix Pharmaceuticals, Inc.

Attorney

Nicole E. Reifman

Filing Date

Oct 4, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PRO-XTEN Trademark

Serial Number: 97059027

PRO-XTEN is a trademark filed by Amunix Pharmaceuticals, Inc. on October 4, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Amunix Pharmaceuticals, Inc. (6 trademarks)

2 Tower Pl, #1100
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

October 4, 2021

Registration Date

Not Registered

Published for Opposition

July 19, 2022

Goods & Services

Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant and synthetic polypeptides for universal masking of proteins and providing half-life extension, and protease-cleavable linkers to enable unmasking

Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology for the treatment of cancerous diseases; medical diagnostic reagents

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 28, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 28, 2026 ABN2
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Aug 8, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Aug 8, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Aug 8, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 7, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 7, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 7, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 7, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 7, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2024 CRFA
ASSIGNED TO LIE
Dec 10, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2024 TROA
SOU TEAS EXTENSION RECEIVED
Sep 13, 2024 EEXT
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 2, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 2, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 4, 2024 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2024 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Apr 3, 2024 SUPC
SOU EXTENSION 3 GRANTED
Apr 3, 2024 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2024 AITU
USE AMENDMENT FILED
Mar 13, 2024 IUAF
SOU EXTENSION 3 FILED
Mar 13, 2024 EXT3
TEAS STATEMENT OF USE RECEIVED
Mar 13, 2024 EISU
SOU TEAS EXTENSION RECEIVED
Mar 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 13, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 13, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 6, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2022 CNEA
ASSIGNED TO EXAMINER
Jun 2, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2021 NWOS
NEW APPLICATION ENTERED
Oct 7, 2021 NWAP

Related Trademarks

More from this Owner

PRO-XTEN

PRO-XTEN

PRO-XTEN

PRO-XTEN

PRO-XTEN

PRO-XTEN

XPAC

XPAC

XPAC

XPAC

XPAC

XPAC